Latest Capital Partnering News

Alvo Minerals has raised $2.26 million through a placement to accelerate drilling and exploration at its Palma Copper-Zinc Project in Brazil, including the promising new Touro Prospect.

Elanor Investors Group has extended deadlines for a $125 million investment from Rockworth Capital Partners and the acquisition of Firmus, with a key shareholder meeting now scheduled for late January 2026.

HMC Capital has secured an increased and extended revolving debt facility, enhancing its underwriting capacity and supporting strategic growth initiatives, including its energy transition efforts.

Dotz Nano has extended the maturity dates of key convertible notes held by Mercer Street Capital Partners, signaling sustained investor confidence in its carbon capture technology and growth plans.

Navigator Global Investments delivered record financial results in FY25, driven by strong revenue growth and strategic expansion, while suspending dividends to fuel future growth. Key leadership changes mark a new chapter for the alternative asset manager.

Infratil Limited reported a 7% rise in operational EBITDAF to NZ$514 million for the first half of FY26, driven by strong performances from Longroad Energy and CDC Data Centres. The company also announced significant divestments, including its 20% stake in Fortysouth and a legacy property asset, while maintaining its interim dividend.

Mayfield Group Holdings has completed a $30.5 million private placement and launched a $3 million share purchase plan to fund growth initiatives, including acquisitions and capacity expansion.

Eden Innovations has successfully raised $4.35 million through a placement of shortfall securities, marking a key step in its financial reconstruction and global expansion plans.

Eden Innovations has raised $4.35 million through a placement of shortfall shares, marking a key step in its financial reconstruction and global commercialisation plans.

BrainChip Holdings Ltd has launched a fully underwritten $35 million placement alongside a $2 million share purchase plan to fund the commercialization of its Akida 2.0 technology and new TENNs product development. The capital raise underscores the company’s commitment to expanding its footprint in the rapidly growing edge AI market.

Jindalee Lithium has repurchased all remaining convertible securities from Mercer Street Global Opportunity Fund II and C/M Capital Partners following a successful $8 million capital raise, simplifying its financial structure ahead of advancing the McDermitt Lithium Project.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.